China's Ministry of Health, together with the State Food and Drug Administration, has issued an order preventing hospitals and clinics from offering unapproved stem cell treatments, which attract both local and foreign patients. Applications for stem cell projects will also be rejected by the ministry until July as part of the government's one-year campaign to improve industry regulations.
China halts unapproved stem cell therapies, trials
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group